Lutetium PSMA Therapy Cost in India starts from US $6,000 and varies depending on your medical condition and history, comorbidities, if any, treating doctor, facility and the city where you choose to get the treatment done.
An important expense when it comes to your lutetium PSMA therapy is going to be your oncologist's fees. IndiCure recommends highly experienced, skilled, board-certified doctors who are capable of delivering successful therapies. Although the charges may vary depending on the experience of the doctor, you can be assured that you are in safe and skilled hands when you choose cancer treatment in India with IndiCure.
Having your lutetium PSMA therapy in an accredited facility by skilled and qualified medical staff is a critical factor. Moreover, the geographical location of this facility in India also affects the quote. But, IndiCure provides you with a projected estimate that will be all inclusive and affordable.
We at IndiCure, understand that you travel with a budget in mind and do not like to be greeted by surprises after arrival in India. We thus club all these expenses and give you the package cost that is inclusive and affordable at the same time.
Your case manager shall give you an estimated cost of your surgery after discussing your medical reports with the surgeon. The final cost, however, shall be confirmed after your consultation with the surgeon.
We Help you Choose the Right Treatment, Surgeon & Hospital
We Arrange Video/Telephonic Consultation with the Surgeon
We Assist you with Visa & Accommodation
We Receive you at the Airport and Drop you at Hotel/Hospital
We Assist you the at Hospital & Provide Post Operative Support
In fact, we have Special Negotiated Rates with the Hospitals and you can avail Discounted Rates when you choose to Travel with IndiCure.
Mumbai
Wockhardt Hospitals is the branch of the leading Wockhardt pharmaceutical company in India. The company is more than four decades old and is present in more than 20 countries around the globe. Wockhardt has 9 hospitals in India in Mumbai, Nagpur, Rajkot, Nashik, and Surat.
Gurgaon
Artemis Health Institute, a premium multi-specialty hospital is a healthcare venture launched by the promoters of the Apollo Tyres Group. Established in 2007, Artemis was the first hospital in Haryana to get NABH accreditation within 3 years of start-up.
PSMA (Prostate Specific Membrane Antigen) treatment with lutetium-177 is a type of radionuclide therapy used to kill prostate cancer cells that have migrated to other regions of the body, such as lymph nodes and bones. The eradication of prostate cancer cells may extend life expectancy and ease symptoms such as bone discomfort, which are commonly associated with cancer deposits in the skeleton.
Currently, Lutetium-177 PSMA is used in patients with metastatic prostate cancer who have failed other forms of treatment such as hormone therapy or chemotherapy. Before commencing treatment, patients will need to undergo a PSMA PET-CT scan to confirm PSMA receptors on the cancer cells, which will be targeted by Lutetium-177 PSMA.
Lutetium-177 PSMA is administered by injection into the bloodstream every 6-8 weeks. An intravenous line is established on the day of therapy, and the Lutetium-177 PSMA is infused over 30 minutes.
Antiemetics and a diuretic (to promote urine clearance) are also given at the same time. After 24-72 hours, a SPECT scan is performed to check that disease areas have been effectively targeted. The majority of individuals require four therapy cycles.
A repeat PSMA PET-CT is conducted after two cycles to assess therapy response. If the PSA levels have lowered and a repeat PSMA scan shows a good response, further two cycles will be given to complete the full treatment course of four cycles.
Around 60-70 percent of patients who receive the treatment will have a positive reaction (e.g., symptom relief), and in some cases, it may result in a reasonably long-term illness remission. It is also possible to extend one's life expectancy.
We at IndiCure completely understand your concerns and it is always our endeavor to provide the best outcome for every patient. Following is the list of questions you must ask before you embark on your journey for Lutetium PSMA Therapy in India.
Prepare to answer questions about your:
Lutetium-177 is a radioactive material that emits beta radiation, which is a type of radiation that is harmful to living things. Lutetium-177 is attached to a short peptide that binds to the PSMA receptor on the surface of cancer cells. When the Lutetium 177 - PSMA complex is coupled to a prostate cancer cell, it produces lethal radiation, causing the cancer cell to die. The surrounding normal cells are spared due to the low penetration of the released beta particle.
Lu177 PSMA is injected into the vein. The patient is admitted to the hospital and will be there for the next 24 hours. Prior to the Lu177 PSMA injection, a MAG3/EC scan is performed to assess kidney function.
Intravenous fluids are normally given to the patient before and after the Lu177 PSMA is given throughout a 24-hour period.
PSMA Lu177 is well tolerated. A little dry mouth, tiredness, and nausea are the most prevalent adverse effects. About 2-3 weeks following the Lu177 PSMA delivery, there may be a modest drop in white blood cells and platelets. These side effects are usually mild and transitory, and they go away on their own without any active therapy. Serious or life-threatening consequences are relatively uncommon.
Lu177 PSMA response rates are determined by the tumor biology of prostate cancer, the initial Gleason Score, the degree of illness, and prior therapy responses. Lu177 PSMA therapy typically results in a drop in S. PSA and a shrinking of tumors in more than 70% of patients. By the second dosage of therapy, nearly all patients have experienced a reduction in pain and an improvement in overall health.
Lu PSMA Therapy is a particularly precise therapy that is used to treat metastatic prostate cancer or when other methods of treatment are no longer effective. Patients with advanced castration-resistant metastatic prostate cancer who have shown indications of tumor progression are candidates for this treatment. The following symptoms may appear as cancer progresses:
Enhance your medical journey to India by availing these extra services.
Traveling abroad for medical reasons may be challenging. With our experience of over a decade and working with the best surgeons and top hospitals in India, we help make your medical tour easier and safer for you. We will guide you at every step of the way and make end-to-end arrangements for your surgery, travel, and stay.
Ramandeep Dhaliwal
I had great experience having rhinoplasty through Indicure. Dr. Ruchika from Indicure has helped me in finding best plastic surgeon, answering all my questions...
Read More
Joshua Archer
My name is Joshua Archer I'm from New Zealand, bay of plenty, kawerau I opted for the bypass surgery in January 2023 but planned it in advance for 28 September found IndiCure...
Read More
Kera Ren
Absolutely loved my experience with IndiCure - from first inquiring to meeting the surgeon pre op to my follow up post op. The surgeon was extremely approachable...
Read More
Andreana Paul
Had a wonderful experience. Visited India for my plastic surgery. From sending mails, airport pickup, comfortable accommodation and, to smooth hospital appointment booking...
Read More
Brandi Luce
I had the privilege of using Indicure's services for a cosmetic procedure that I had wanted for a long time but had always been apprehensive about. Ruchika helped me...
Read More
Jade M
Indicure Health Tours went above and beyond my expectations. They helped me with every aspect of my journey and were professional, kind and caring. I was...
Read More
The content on the website (www.indicure.com) is intended to be general information and is provided only as a service. It is not medical advice and should not be taken as medical advice. It should not be used to diagnose or treat a health condition and is in no way meant to be a substitute for professional medical care.
All photographs on our website of before and after results are examples only, and do not constitute an implied or any other kind of certainty for the result of surgery. You are advised to see a surgeon in person to assess what surgery may or may not accomplish for you.
It is also important to keep your expectations realistic and to understand that all surgical procedures carry risks and should never be taken lightly.